Bromberg J, Issa S, Bukanina K, et al. Effect of Rituximab in Primary Central Nervous System Lymphoma – results of the Randomized Phase III HOVON 105/ALLG NHL 24 Study. ASH 59th Annual Meeting & Exhibition, abstract 582.
Fysieke inactiviteit de grootste modificeerbare risicofactor in de geneeskunde
jan 2024 | Leukemie, Lymfoom, MDS, MM, MPN